Center for Lyme Action Welcomes Meghan Bradshaw as New Executive Director
The Center for Lyme Action (CLA), a prominent nonprofit organization committed to raising federal funding for Lyme and tick-borne diseases, has announced the appointment of Meghan Bradshaw as its new Executive Director. This transition comes as the organization prepares for its 6th Annual Advocacy Day, scheduled for February 18, 2025.
A Leader with Experience
Meghan Bradshaw, who holds a Master of Public Health, possesses a wealth of experience in policy and advocacy that makes her a perfect candidate for this crucial role. Having previously led government relations for CLA, she has a proven record of successfully advocating for Lyme disease issues on Capitol Hill. Her ability to translate the voices of patients and clinicians into effective federal policy has been instrumental in increasing funding for Lyme and tick-borne diseases in recent years. Under her leadership, CLA hopes to build on its prior successes and reach out to more bipartisan supporters.
"With the assistance of nearly 10,000 advocates, CLA has achieved significant milestones over the past six years, including an impressive $500 million increase in funding for Lyme disease and related tick-borne illnesses," said Bradshaw. "I look forward to enhancing our advocacy efforts as we aim to secure more federal funding and advance policies like the Kay Hagan Tick Act."
A Personal Journey
The proactivity Bradshaw exhibits is rooted not only in her professional expertise but also her personal experiences as a Lyme disease patient. Co-founder Bonnie Crater recognized her dedication from the outset, stating, "From the beginning, Meghan worked on appropriations forms from her bed, showcasing her commitment even during her toughest times. Despite her personal challenges, she equipped herself with a Master's degree and took charge of CLA's government relations with great success."
In addition to Bradshaw, the governing board of CLA will include Bonnie Crater and co-founder Jeff Crater, along with Monika Cheney, ensuring a smooth leadership transition and continuity in mission focus.
Upcoming Advocacy Day
On February 18, 2025, CLA will hold its Virtual Advocacy Day, an essential event aimed at bringing together patients, healthcare professionals, researchers, and advocates to discuss Lyme and related illnesses as urgent public health concerns. During this virtual event, participants will have the opportunity to communicate directly with members of Congress via Zoom. They will share personal stories, highlight critical research needs, and stress the importance of ongoing federal investment in prevention, diagnosis, and treatment of Lyme disease.
This day of advocacy aims to amplify the voices of those affected by Lyme and tick-borne diseases, raising the profile of this often-overlooked public health crisis. Interested individuals are encouraged to register before the January 30 deadline at
centerforlymeaction.org/events.
About Center for Lyme Action
Center for Lyme Action, a 501c4 nonprofit organization, is dedicated to increasing federal funding for Lyme, Alpha-gal, and tick-borne diseases. By focusing on these issues, CLA seeks to raise awareness about the human impact of Lyme disease and the urgent necessity for improved diagnostic and treatment options. The organization is supported by its members and visionary funding from groups like the Bay Area Lyme Foundation and Project Lyme.
For more information about CLA, upcoming events, and advocacy efforts, visit
CenterForLymeAction.org.